About dianova
Founded in 1982, dianova develops and supplies high-quality antibodies for research and diagnostics. Since 2020, it has operated as part of BIOZOL and the Calibre Scientific group. The company combines antibody expertise with an international distribution network. Its portfolio includes primary and secondary antibodies for reliable protein and biomarker detection across multiple workflows. It also offers antibodies for human pathology, including reagents optimised for formalin-fixed, paraffin-embedded tissues used in immunohistochemistry.
The dianova portfolio includes proprietary primary antibodies and more than 1,500 secondary antibodies with high specificity, sensitivity and reproducibility. These reagents support immunohistochemistry, immunofluorescence, Western blotting and ELISA. The company collaborates with pathology institutes to expand its IHC antibody range for translational and clinical research. Its antibody technologies help researchers identify and characterise biological targets in tissues and experimental samples.
Europa Biosite’s subsidiaries distribute for dianova in Ireland, Switzerland and the United Kingdom.